The Center for Biotechnology & Interdisciplinary Studies at Rensselaer

The Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute interweaves life sciences, physical sciences, and engineering into the fields of biotechnology and medicine, opening exciting new pathways to innovation and discovery. From complex biological networks to nanoscale assemblies that mimic biological processes, CBIS is a powerhouse of academic and research advancement. More than 200 CBIS scientists and engineers are working here to uncover the molecular basis of biological mechanisms and disease, using biological systems as the basis for new therapeutics, and developing new cellular niches critical in tissue regeneration. More about CBIS

Over Ten Years

  • 40 Faculty
  • 200 Ph.D.s Granted
  • 1,000 Undergrads Trained
  • 2,000 Peer-Reviewed Publications
  • 30,000 Citations (ISI)
  • $130MExternal Grant Funding

News & Events

Salt-Evolved Zooplankton Grow Too Slowly To Block Salt-Induced Algal Blooms

Small animals at the base of the freshwater food chain can rapidly adapt to salt pollution – from sources like winter road deicing, agriculture, and mining – but at a price.

Research Focuses on a New Frontier in Circadian Rhythms

A new frontier in the science of circadian rhythms – whose disruption is linked to major diseases like cancer and diabetes – suggests a previously unknown mechanism at work in our daily biological cycle.

Biocatalysis Expert Richard Gross Recognized for Economical Environmental Chemical Advances

The American Chemical Society (ACS) has recognized biocatalysis expert Richard Gross with the 2019 ACS Award for Affordable Green Chemistry, bestowed for outstanding scientific discoveries or chemistries that lay the foundation for cost-competitive environmentally friendly products or manufacturing processes that are less expensive than existing alternatives.

Flipped Cells Cause Blood Vessels To Leak in Diabetes and Other Diseases

An enzyme activated in diabetics has been found to cause previously aligned cells in a blood vessel to reverse their orientation, creating misalignments that allow veins and arteries to leak three times more blood proteins than normally constructed blood vessels.

Research Seeks Candidates for Alzheimer’s Drug to Block Production of Amyloid Peptide

With support from the Warren Alpert Foundation, researchers at Rensselaer Polytechnic Institute have launched a search for drug candidates to block a biological process associated with Alzheimer’s disease.

Our Center

  • 150 PhD Students
  • 50 Postdoctoral Fellows
  • 33 Principal Investigator Laboratories
  • 25 Visiting Research Scientists
  • 218,000 sq ft modern facility
  • 31, 240 sq ft of open research labs
  • 13,009 sq ft of support labs
  • 27,350 sq ft of core facilities
  • 5,830 sq ft conference and seminar space

In the News